Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
02/2004
02/19/2004WO2003095605A3 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors
02/19/2004WO2003087318A3 Truncated 24 kda basic fibroblast growth factor
02/19/2004WO2003084986A3 Novel purified polypeptides involved in cellular metabolism
02/19/2004WO2003080640B1 Lymphatic and blood endothelial cell genes
02/19/2004WO2003052051A3 Adeno-associated virus (aav) serotype 8 sequences
02/19/2004WO2003050265A3 Compositions and methods for normalizing assays
02/19/2004WO2003048193A3 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN
02/19/2004WO2003031596A3 Production of a highly active, soluble form of the cytochrome p450 reductase (cpr a) from candida tropicalis
02/19/2004WO2003010294A3 Genes involved in the biosynthesis of isopentenyl diphosphate in hevea brasiliensis latex
02/19/2004WO2003008537A9 Epitope sequences
02/19/2004WO2003000051B1 Novel biofungicide
02/19/2004WO2002083866A3 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
02/19/2004WO2002081496A3 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
02/19/2004WO2002074251A3 Monoclonal antibody therapy for pancreas cancer
02/19/2004WO2002066616A3 Engineering fungi for the utilisation of l-arabinose
02/19/2004WO2002061086A3 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
02/19/2004WO2002048337A3 Secreted human proteins
02/19/2004WO2002038788A3 Process for the fermentative preparation of l-amino acids using coryneform bacteria
02/19/2004US20040034197 Biosynthesizing trypsin and/or trypsinogen amino acid sequences, analogs and catalytic polypeptides with altered active sites and binding domains which recognize and bind to ester leaving groups
02/19/2004US20040034195 Multimerized highly functional antifreeze protein
02/19/2004US20040033975 Whole cell engineering using real-time metabolic flux analysis
02/19/2004US20040033953 Cry proteins; endotoxins
02/19/2004US20040033595 Conditionally replicating vectors for inhibiting viral infections
02/19/2004US20040033586 Pasteurella and/or actinobacillus mutant coding polypeptide for prevention and treatment of infectious disease; veterinary medicine
02/19/2004US20040033580 Thermopallium culture for fermenting alkaline favorable, heat resistant pullulanase and/or amylase for use in detergent, paper, pulp and textile industry
02/19/2004US20040033579 Substantially pure reverse transcriptases and methods of production thereof
02/19/2004US20040033577 Herbicides test method
02/19/2004US20040033576 Using crystalline cell surface protein for directed monomolecular bonding of molecular layers and/or their attachment to solid support; immobilized cells; micelles
02/19/2004US20040033574 Providing an aryl silane substrate having at least one aromatic component and at least one silicon atom, contacting a dioxygenase enzyme with the substrate to convert the aryl silane substrate to a corresponding cis-diol
02/19/2004US20040033572 Polyhydroxyalkanoate biopolymer compositions
02/19/2004US20040033567 Using genetically engineered bacillus to ferment and recover amylase, cellulase, lipase, an oxidoreductase, a carbohydrolase and/or a non-destructive protease or peptidase from nutrient broth
02/19/2004US20040033565 Isolated human G-Protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
02/19/2004US20040033556 Monascus purpureus mutant and its use in preparing yellow pigment
02/19/2004US20040033548 Compositions and methods for regulating bacterial pathogenesis
02/19/2004US20040033527 Methods of using a three-dimensional model of a Fc epsilon receptor alpha chain
02/19/2004US20040033526 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
02/19/2004US20040033511 Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines)
02/19/2004US20040033494 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods
02/19/2004US20040033491 Proteins and nucleic acids encoding same
02/19/2004US20040033481 Preparing and designing antigrowth modulators which inhibit methionyl-tRNA synthetase activities in microscopic pathogens
02/19/2004US20040033479 Preparing transformation capable or transgenic aggregates for use as bioreactors in expressing heterologous proteins
02/19/2004US20040033238 Selectable genetic marker for use in pasteurellaceae species
02/19/2004US20040033236 Recombinant constructs of borrelia burgdorferi
02/19/2004US20040033229 PSMA antibodies and protein multimers
02/19/2004US20040031447 Animal papilla disinfectants and method of improving microbial environment
02/19/2004DE10235028A1 Verfahren zur Herstellung von L-Lysin unter Verwendung coryneformer Bakterien A method for producing L-lysine using coryneform bacteria
02/19/2004CA2496002A1 Albumin-fused ciliary neurotrophic factor
02/19/2004CA2495121A1 Nogo receptor antagonists
02/19/2004CA2494988A1 Heterologous expression system comprising a b. subtilis promoter
02/19/2004CA2494742A1 Tiacumicin production
02/19/2004CA2493977A1 Vaccine composition comprising lipooligosaccharide with reduced phase variability
02/19/2004CA2493124A1 Vaccine
02/19/2004CA2493092A1 Neisserial vaccine compositions comprising a combination of antigens
02/19/2004CA2489030A1 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
02/18/2004EP1389239A2 Methods and compositions for making emamectin
02/18/2004EP1389238A2 Regulation of human prostaglandin-f synthase 1-like protein
02/18/2004EP1389235A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
02/18/2004EP1389233A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
02/18/2004EP1389228A2 0etergent compositions comprising bacillus subtilis pectate lyases
02/18/2004EP1389186A2 Recombinant simian gpr3 receptor
02/18/2004EP1389133A1 Methods for inactivating viruses
02/18/2004EP1177309B1 Clostridium strains which produce ethanol from substrate-containing gases
02/18/2004EP1123314B1 Use of a cytokine-producing lactococcus strain to treat colitis
02/18/2004EP0751995B1 Riboflavin synthesis in fungi
02/18/2004EP0663011B1 Synthesis of quinic acid from glucose
02/18/2004CN1476481A Isolated luciferases and use thereof
02/18/2004CN1476479A Human protooncogene and protein encoded therein
02/18/2004CN1476478A Human cervical cancer 2 protooncogene and protein encoded therein
02/18/2004CN1475572A High expressed high temperature resistant phytase gene in methanol yeast
02/18/2004CN1475565A Yeast expression high specic activity phytase gene obtained using chemical synthesis and molecular evolution
02/18/2004CN1475563A Method of proceeding gene conversion against orchid using agriculturel bacillus induction
02/18/2004CN1475561A Process for producing L-lysine by fermenting
02/18/2004CN1475560A Composite biological fungus agent
02/18/2004CN1475559A Breeding method of acid resistant mutagenic ore immersion bacterial culture
02/18/2004CN1475467A Bamboo forest biological fertilizer
02/18/2004CN1475138A 猪饲料添加剂 Pig feed additive
02/18/2004CN1475137A Chicken feed additive
02/18/2004CN1475136A 鱼饲料添加剂 Fish feed additive
02/18/2004CN1475135A Shrimp feed additive
02/18/2004CN1475101A Agaric pilose mixed fungus fermentation culturing method and its culturing medium and product
02/18/2004CN1138861C Microbial 11 alpha-hydroxylation of steroids
02/18/2004CN1138857C Zymolase of agricultural chemical containing organic phosphorus and its coding gene and preparing process
02/18/2004CN1138856C Engineering bacteria for epidermal growth factor and preparation of epidermal growth factor by using this bacteria
02/18/2004CN1138563C Vector for diagnosis and treatment of solid tumors including melanoma
02/18/2004CN1138551C Eipthelial adhesive lactobacilli
02/18/2004CN1138472C Dipeptide apoptosis inhibitors and use thereof
02/17/2004US6693085 Has an activity against mrsa (methicillin-resistant staphylococcus aureus).
02/17/2004US6692951 Protein particle for use as genetic engineering tool in expression of heterologous proteins in bacillus
02/17/2004US6692950 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid
02/17/2004US6692946 Polynucleotides encoding the nadA gene and methods of producing nicotinic acid or nicotinic acid derivatives
02/17/2004US6692943 Persephin and related growth factors
02/17/2004US6692938 Peptide for use in the treatment of inflammation, arthritis, glomerulonephritis, asthma, psoriasis, viral infections, cancer, atherosclerosis, leukemia and autoimmune diseases
02/17/2004US6692937 Nucleotide sequences coding membrane protein for use in the treatment of cancer, infection and heart defects
02/17/2004US6692936 Novel polypeptide belonging to the class of proteins known as g-protein coupled receptors
02/17/2004US6692935 Fusion of peptide or protein association domains designed to assemble in a complementary fashion, thereby providing multifunctional (poly)peptides
02/17/2004US6692932 Thermostable DNA polymerase from anaerocellum thermophilum
02/17/2004US6692930 Immunoglobulin for use in the detection of preferential meats; for use in accurately labeling meats
02/17/2004US6692929 Polypeptide; for use in detection of cell cycle modulators
02/17/2004US6692748 Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2
02/17/2004US6692747 Peptide for use in the treatment of infections, viral and cancer diseases